Real-time Estimate
Cboe Europe
03:17:38 2025-01-15 am EST
5-day change
1st Jan Change
108.60 CHF
-0.37%
-4.23%
+2.06%
Medacta Group Reports Growth in H1 Attributable Profit, Revenue
September 25, 2024 at 01:31 am EDT
This article is reserved for members
Not a member ?
Free registration
Swiss Market Index Advances Ahead of SNB's Rate Decision Day
24-09-25
MT
Medacta Group SA - Analyst/Investor Day
24-09-25
Medacta Group Reports Growth in H1 Attributable Profit, Revenue
24-09-25
MT
Medacta's Profitability at Risk Amid Expected Sales Slowdown in H1, Morgan Stanley Says
24-09-24
MT
Medacta Group SA Reports Earnings Results for the Half Year Ended June 30, 2024
24-09-23
CI
Medacta Group, Think Surgical Partner in US for Robotic Total Knee Arthroplasty Solution
24-08-30
MT
Medacta Group, Mighty Oak Medical Settle Patent Dispute via New License Deal
24-08-28
MT
Medacta Group SA, H1 2024 Earnings Call, Jul 25, 2024
24-07-25
Medacta Group SA Provides Earnings Guidance for the Year 2024
24-03-13
CI
Medacta Group SA, 2023 Earnings Call, Mar 13, 2024
24-03-13
Medacta Group SA Reports Earnings Results for the Full Year Ended December 31, 2023
24-03-12
CI
Medacta Enters Collaboration for RFID Technology in Healthcare Business
24-02-20
MT
Medacta Group SA, 2023 Sales/ Trading Statement Call, Feb 02, 2024
24-02-02
Medacta Group Books 17% Jump in FY23 Revenue
24-02-02
MT
Medacta to Expand Swiss Facilities to Boost Production Capacity
23-11-30
MT
Medacta Group to Launch Optimized Knee Implant
23-10-30
MT
Medacta's New Study Shows Accuracy of NextAR Shoulder Application
23-10-13
MT
Medacta Group SA, Q2 2023 Earnings Call, Sep 22, 2023
23-09-22
Medacta Group Reports Higher H1 Attributable Profit, Revenue
23-09-22
MT
Medacta Group SA Reports Earnings Results for the Half Year Ended June 30, 2023
23-09-20
CI
Medacta Group SA, H1 2023 Sales/ Trading Statement Call, Jul 28, 2023
23-07-28
Medacta Posts 21% Increase in H1 Revenue; Raises FY23 Guidance
23-07-28
MT
Medacta Group SA Announces Unaudited Revenue Results for the First Half Ended June 30, 2023
23-07-28
CI
Medacta Group SA Updates Revenue Guidance for the Year 2023
23-07-28
CI
Global markets live: Enel, ASML, Adobe, Nikola...
23-07-05
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
MOVE: Dynamic Chart
Medacta International SA is a Swiss-based company specialized in medical devices. The Company develops, manufactures and distributes orthopaedic and neurosurgical medical devices. The Company designs a number of products, such as hip products, including hip replacement, hip anatomy, hip diseases, and other products for the preparation of hip surgery; knee product, which encompasses knee anatomy, knee diseases, knee replacement, the stability of the knee and for the preparation of knee surgery; shoulder product, which includes shoulder anatomy, shoulder disease, shoulder replacement, and for the preparation of shoulder operation, and spine product, which includes products for spinal treatments, spinal anatomy and for surgery, among others. Additionally, the Company also offers training and support to healthcare professionals.
More about the company
Last Close Price
115.81 EUR
Average target price
150.19 EUR
Spread / Average Target
+29.68%
Consensus
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1